Jiangxi Synergy Pharmaceutical (300636.SZ): Vildagliptin tablets obtain drug registration certificate.
Unity Pharmaceutical (300636.SZ) announced that the company recently received a notice from the National Medical Products Administration (referred to as the "National Medical Administration...
Jiangxi Synergy Pharmaceutical (300636.SZ) announced that the company recently received the Drug Registration Certificate for Vildagliptin Tablets issued by the National Medical Products Administration (NMPA). Vildagliptin Tablets are used for the treatment of type 2 diabetes.
Related Articles
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
